Next-Generation Radiopharmaceuticals: What’s on the Horizon? Presenter Dr.
Ken Herrmann 🇩🇪
Three phase 3 trials—VISION, PSMAfore, and PSMAddition—have established lutetium-177–PSMA radioligand therapy as a key option in metastatic prostate cancer.
Next-Generation Radiopharmaceuticals: What’s on the Horizon? Presenter Dr.
Ken Herrmann 🇩🇪
Three phase 3 trials—VISION, PSMAfore, and PSMAddition—have established lutetium-177–PSMA radioligand therapy as a key option in metastatic prostate cancer.
Radioligand Therapies: How to improve outcomes? Abstract Presenter Michael Hofman 🇦🇺
Radioligand therapy is reshaping advanced prostate cancer care, with outcomes hinging on optimized delivery and biological insight. Acting as “liquid radiation,”
Radioligand Therapies: How to improve outcomes? Abstract Presenter Michael Hofman 🇦🇺
Radioligand therapy is reshaping advanced prostate cancer care, with outcomes hinging on optimized delivery and biological insight. Acting as “liquid radiation,”
Novel T-cells Engagers in Prostate Cancer Presenter Dr. Johann de Bono 🇬🇧
T-cell engagers (TCEs), including bispecific and trispecific constructs, are promising immunotherapies in prostate cancer, targeting antigens such as PSMA, STEAP1, DLL3, KLK2,
Novel T-cells Engagers in Prostate Cancer Presenter Dr. Johann de Bono 🇬🇧
T-cell engagers (TCEs), including bispecific and trispecific constructs, are promising immunotherapies in prostate cancer, targeting antigens such as PSMA, STEAP1, DLL3, KLK2,
Immune response pattern in prostate cancer Presenter Dr. Andrea Alimonti 🇨🇭
Prostate cancer harbors heterogeneous tumor-infiltrating neutrophils that shape disease progression and therapy response.
#ProstateCancer #ProstateCancerWeek
Immune response pattern in prostate cancer Presenter Dr. Andrea Alimonti 🇨🇭
Prostate cancer harbors heterogeneous tumor-infiltrating neutrophils that shape disease progression and therapy response.
#ProstateCancer #ProstateCancerWeek
Detection of Neuroendocrine Prostate Cancer via DNA Methylation Presenter Dr. Himisha Beltran 🇺🇸
Integrative epigenetic analyses reveal distinct DNA methylation, histone, and transcriptional signatures that differentiate NEPfrom adenocarcinoma
Detection of Neuroendocrine Prostate Cancer via DNA Methylation Presenter Dr. Himisha Beltran 🇺🇸
Integrative epigenetic analyses reveal distinct DNA methylation, histone, and transcriptional signatures that differentiate NEPfrom adenocarcinoma
A warm welcome to all from Co Chair Dr. Jean-Phillipe Theurillat 🇨🇭
REGISTRATION 👉 apccc.org/register/?ut...
2026 International Prostate Cancer Symposium (IPCS) 📅 April 28–29, 2026 | 📍 Lugano, Switzerland @IPCSymposium
A warm welcome to all from Co Chair Dr. Jean-Phillipe Theurillat 🇨🇭
REGISTRATION 👉 apccc.org/register/?ut...
2026 International Prostate Cancer Symposium (IPCS) 📅 April 28–29, 2026 | 📍 Lugano, Switzerland @IPCSymposium
Preventing Disease Progression under AR suppression Through TRIM24 Degradation. Presenter: Jean-Phillipe Theurillat 🇨🇭
#ProstateCancer #ProstateCancerWeek
Preventing Disease Progression under AR suppression Through TRIM24 Degradation. Presenter: Jean-Phillipe Theurillat 🇨🇭
#ProstateCancer #ProstateCancerWeek
Targeting heterogeneity in metastatic prostate cancer to prevent resistance. Presenter: Peter S. Nelson🇺🇸
#ProstateCancer #ProstateCancerWeek
Targeting heterogeneity in metastatic prostate cancer to prevent resistance. Presenter: Peter S. Nelson🇺🇸
#ProstateCancer #ProstateCancerWeek
Androgen Receptor Action in Prostate Cancer: it’s a numbers game
Presenter Dr. Wilbert Zwart 🇳🇱
Androgen receptor (AR) signaling drives prostate cancer through complex, large-scale chromatin interactions involving many cofactors and gene targets.
Androgen Receptor Action in Prostate Cancer: it’s a numbers game
Presenter Dr. Wilbert Zwart 🇳🇱
Androgen receptor (AR) signaling drives prostate cancer through complex, large-scale chromatin interactions involving many cofactors and gene targets.
Targeted protein degradation for regulation of nuclear hormone receptors. PresenterNicolas Thomä 🇨🇭
#ProstateCancer #ProstateCancerWeek
Targeted protein degradation for regulation of nuclear hormone receptors. PresenterNicolas Thomä 🇨🇭
#ProstateCancer #ProstateCancerWeek
REGISTRATION 👉 buff.ly/9hvqRn0...
Discounted Price if combined Registration for #IPCS26 and #APCCC26
REGISTRATION 👉 buff.ly/9hvqRn0...
Discounted Price if combined Registration for #IPCS26 and #APCCC26
A warm welcome to the #APCCC5k , a great way to start the day with a fun Run/Walk around Lake Lugano Switzerland. More details once you get to Lugano, but just reminding our colleagues...Bring your Running shoes, we will :-)
REGISTRATION 👉 buff.ly/9hvqRn0...
Discounted Price if combined Registration for #IPCS26 and #APCCC26
REGISTRATION 👉 buff.ly/9hvqRn0...
Discounted Price if combined Registration for #IPCS26 and #APCCC26
REGISTRATION 👉 buff.ly/9hvqRn0...
Discounted Price if combined Registration for #IPCS26 and #APCCC26
Join global leaders in prostate cancer research
REGISTRATION 👉 buff.ly/9hvqRn0...
Discounted Price if combined Registration for #IPCS26 and #APCCC26
Join global leaders in prostate cancer research
REGISTRATION 👉 buff.ly/9hvqRn0...
Discounted Price if combined Registration for #IPCS26 and #APCCC26
REGISTRATION 👉 buff.ly/9hvqRn0...
Discounted Price if combined Registration for #IPCS26 and #APCCC26
REGISTRATION 👉 buff.ly/9hvqRn0...
Discounted Price if combined Registration for #IPCS26 and #APCCC26
REGISTRATION 👉 buff.ly/9hvqRn0...
Discounted Price if combined Registration for #IPCS26 and #APCCC26
REGISTRATION 👉 buff.ly/9hvqRn0...
EARLY BIRD Registration ends 2/28/26
Discounted Price if combined Registration for #IPCS26 and #APCCC26
REGISTRATION 👉 buff.ly/9hvqRn0...
EARLY BIRD Registration ends 2/28/26
Discounted Price if combined Registration for #IPCS26 and #APCCC26
👉 Secure your spot before February 28: apccc.org/apccc-2026/r...
👉 Secure your spot before February 28: apccc.org/apccc-2026/r...
📍 28 April-2 May 2026, Palazzo Congressi, Lugano, Switzerland
🎟️ Register here: onlineevent.ch/APCCC/2026
🎓 Credits requests: SGU – SSU, SSMO, SRO, SGMN, ECTS and Animal welfare training (FBA)
📍 28 April-2 May 2026, Palazzo Congressi, Lugano, Switzerland
🎟️ Register here: onlineevent.ch/APCCC/2026
🎓 Credits requests: SGU – SSU, SSMO, SRO, SGMN, ECTS and Animal welfare training (FBA)
apccc.org/ipcs/
Register now for #IPCS26 and #APCCC26 and take advantage of a 20% discount when registering for both events!
Events Details:
📍 28-29 April 2026, Palazzo Congressi, Lugano, Switzerland
🎟️ Register here: onlineevent.ch/APCCC/2026
apccc.org/ipcs/
Register now for #IPCS26 and #APCCC26 and take advantage of a 20% discount when registering for both events!
Events Details:
📍 28-29 April 2026, Palazzo Congressi, Lugano, Switzerland
🎟️ Register here: onlineevent.ch/APCCC/2026
Register now for #IPCS26 and take advantage of:
- early registration fee
- 20% discount when registering for #IPCS26 and #APCCC26
👉 Early registration is open until 28 February 2026
📍 Lugano
🎟️ Register here onlineevent.ch/APCCC/2026
Register now for #IPCS26 and take advantage of:
- early registration fee
- 20% discount when registering for #IPCS26 and #APCCC26
👉 Early registration is open until 28 February 2026
📍 Lugano
🎟️ Register here onlineevent.ch/APCCC/2026
⏳ Only 8 days left to benefit from the early registration fee until 28 February!
Register now for #IPCS26 and #APCCC26 and take advantage of the 20% discount!
🎟️ Register here onlineevent.ch/APCCC/2026
⏳ Only 8 days left to benefit from the early registration fee until 28 February!
Register now for #IPCS26 and #APCCC26 and take advantage of the 20% discount!
🎟️ Register here onlineevent.ch/APCCC/2026